FDA — authorised 9 December 1998
- Application: BLA020032
- Marketing authorisation holder: ABBVIE
- Indication: Manufacturing (CMC)
- Status: approved
🇺🇸 Survanta in United States
FDA authorised Survanta on 9 December 1998
Marketing authorisation
Survanta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in United States
Frequently asked questions
Is Survanta approved in United States?
Yes. FDA authorised it on 9 December 1998.
Who is the marketing authorisation holder for Survanta in United States?
ABBVIE holds the US marketing authorisation.